Bioceres Crop Solutions Corp.
corporate_fare Company Profile
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for BIOX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-11, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 13 rated 8 or above. Recent SEC coverage for BIOX spans 20-F, 6-K, SCHEDULE 13D/A.
Recent high-impact activity:
- Bioceres Q1 Revenue Falls 22%, Net Loss Widens to $10.8M as Liquidity Tightens
- Bioceres 20-F: Going-Concern Doubt, $263.9M FY26 Loss, $110.1M Noteholder Judgment
- Bioceres Faces Summary Judgment Damages in Jasper Lake Ventures Lawsuit
- Bioceres Gets Nasdaq Reprieve: Transfer to Capital Market and 180-Day Extension to Regain $1 Bid
- Bioceres Returns to Positive Adjusted EBITDA in Q4, But Full-Year Loss Widens
Financial Snapshot
Short Interest & Short Volume
1.71 days to coverFINRA reported short interest of 458,064 shares in BIOX as of the October 30, 2026 settlement, a 46.3% decrease from the prior period — about 1.7 days to cover at its recent average daily volume. On November 20, 2026, 28.8% of BIOX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
BIOX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.